Digestive Health News
-
Alfa Chemistry Integrates Its Supply of Dietary Supplement Ingredients
Alfa Chemistry, a reputable global supplier of research chemicals and materials, has recently announced the integration of its dietary supplement ingredients supply. This move aims to streamline the company's operations and enhance its ability to meet the growing demand for high-quality dietary supplement ingredients. Dietary supplements have gained significant popularity in recent years, with ...
-
Creative Enzymes Unveils the Creative SuperCut Series: Redefining Precision in Molecular Biology
Creative Enzymes, a pioneering force in the field of biotechnology, has once again raised the bar in molecular biology with the launch of its Creative SuperCut Series. This breakthrough product line is designed to revolutionize the way scientists approach restriction enzyme digests, making it faster and more efficient than ever before. Creative Enzymes’ Creative SuperCut Series is ...
-
Creative Enzymes Launches Diamine Oxidase (Food-Grade) for Enhanced Food Safety and Digestive Health
Creative Enzymes, a trailblazing leader in the field of enzyme research and manufacturing, is excited to announce its latest innovation: Diamine Oxidase (Food Grade). This product is poised to revolutionize the food industry by significantly bolstering food safety protocols and promoting optimal digestive health. Histamine intolerance, stemming from reduced levels of Diamine Oxidase (DAO), is a ...
-
Creative Enzymes Introduces a Range of Lactobacillus Strains with Enhanced Benefits
Creative Enzymes, a leading provider of innovative enzymes and probiotic solutions, is proud to introduce a range of Lactobacillus strains with enhanced benefits that are designed to revolutionize the way we approach gut health. This high-quality probiotic powder not only offers a wide range of health benefits but also opens up new opportunities for the food and pharmaceutical industries. In ...
-
Creative Enzymes Revolutionizes the Probiotics Industry with Bacillus Coagulans Freeze Dried Powder
Creative Enzymes, a professional enzyme provider located in New York, USA, proudly unveils its high-quality product, Bacillus Coagulans Freeze Dried Powder. This cutting-edge probiotic powder not only offers a multitude of health benefits but also ushers in unprecedented opportunities for the food and pharmaceutical industries. Bacillus Coagulans, a resilient and spore-forming bacterium, has ...
-
More than muscles: Sports nutrition evolves
Ingredients for muscle mass and post-workout recovery remain mainstays in sports nutrition, but the category is evolving and broadening. Ingredient examples are phospholipids for cognition and probiotic cultures for digestive health. “It’s very well-known that health is increasingly perceived holistically by consumers, especially younger demographics,” said Paige Wilkinson, ...
By Nuritas Ltd.
-
Kidney and Pancreas Function Diagnostic Enzymes Are Now Available at Creative Enzymes
Creative Enzymes, a global leader in diagnostic enzyme manufacturing and supply, is dedicated to offering a wide range of enzyme products as well as customized enzyme-related services for medical and research diagnosis. Recently, Creative Enzymes launched kidney and pancreas function diagnostic enzymes for the global market. The primary function of the kidney is to eliminate waste and excess ...
-
Endosomal Signaling Of Delta Opioid Receptors Is An Endogenous Mechanism And Therapeutic Target For Relief From Inflammatory Pain
Whether G protein-coupled receptors signal from endosomes to control important pathophysiological processes and are therapeutic targets is uncertain. We report that opioids from the inflamed colon activate δ-opioid receptors (DOPr) in endosomes of nociceptors. Biopsy samples of inflamed colonic mucosa from patients and mice with colitis released opioids that activated DOPr on nociceptors to ...
-
Iterative Health Partners with Gastro Health to Accelerate Clinical Research in Gastroenterology Through Artificial Intelligence
Iterative Health, a pioneer in precision-medicine technologies for gastroenterology, announced today that it has partnered with Gastro Health, a national leading medical group specializing in digestive and liver health, to bring its AI Recruitment (AIR) technology to Gastro Health’s practices. This strategic partnership will lay the groundwork for future collaborations by using AIR to aid ...
-
Creative Enzymes Provides DNA Molecular Weight Markers and Ladders
Creative Enzymes, an excellent supplier and manufacturer located in New York, is always hammering away at research and trials in order to provide customers with a comprehensive line of enzyme solutions, including products and services. DNA markers and ladders play important roles in molecular biology research. With the aim of developing efficient enzyme tools to better support your research, ...
-
Creative Enzymes Expands Its Service Offering with the Launch of Custom Enzyme Blends
Creative Enzymes, a professional enzyme provider located in New York, USA, is always hammering away at research and trials in order to provide customers with enzyme solutions, including services and products, with its greatest effort. Since enzyme mixtures usually reserve more diverse functions and higher efficiencies than single enzymes, Creative Enzymes is leveraging its ability to provide ...
-
Seres Therapeutics Presents Microbiome Therapeutic Research at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun. 1, 2022-- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, announced the presentation of preclinical data supporting further investigation of a rationally designed microbial consortium candidate (DE486) to prevent or treat gastrointestinal (GI) mucositis – a common and often painful complication of radiation and ...
-
Profacgen Provides Protein Ubiquitination Services to Accelerate Drug Development Project
Profacgen, an experienced provider in biological research and drug discovery, provides various ubiquitin services to help customers accelerate research progress and obtain better results. Ubiquitination is one of the most prevalent post-translational modifications (PTMs) in cells. Ubiquitin modification induces protein degradation, which affects the function, localization, and activity of ...
By Profacgen
-
PepsinCheck: A Direct-to-Consumer Reflux Test for U.S. Consumers
Restech is proud to announce the launch of PepsinCheck, a PEPTEST product branded for the U.S. consumer market. New at-home reflux test can be ordered online at www.pepsincheck.com UK healthcare innovator, RD Biomed, developed Peptest, the world’s first non-invasive test for reflux, in 2007. Since that time it has grown to global prominence. Shipping costs and wait times were a barrier ...
By Restech
-
Palisade Bio Announces Inducement Awards Under Inducement Plan For Key New Hires
Palisade Bio (Nasdaq: PALI), a clinical-stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal complications, today announced that it had made equity grants to four new employees under its 2021 Inducement Plan. On May 4, 2022, the Company’s Compensation Committee granted options to four new non-executive employees covering an aggregate of 140,000 shares ...
By Palisade Bio
-
Palisade Bio Announces $2.0 Million Registered Direct Offering
Palisade Bio, Inc. (Nasdaq: PALI) (the “Company” or “Palisade Bio”), a clinical-stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal complications, today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale in a registered direct offering of 3,646,690 ...
By Palisade Bio
-
Palisade Bio And Newsoara Receive NMPA Clearance To Commence Phase 3 Clinical Trial In China Evaluating LB1148 To Accelerate The Return Of Bowel Function Following Abdominal Surgery
NMPA clearance expands global Phase 3 clinical development program; Company recently announced clearance from U.S. Food and Drug Administration to commence Phase 3 study Newsoara to fully fund Phase 3 program in China Under the Co-Development Agreement, commencement of Phase 3 program in China will trigger milestone payment to Palisade Bio Palisade Bio (Nasdaq: PALI), a clinical stage ...
By Palisade Bio
-
Palisade Bio (Nasdaq: PALI) To Participate In The Virtual Investor Management And KOL Roundtable Event
- Palisade Bio (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today announced that members of management will participate in the Virtual Investor Management and KOL Roundtable Event on Tuesday, May 3, 2022 at 10:00 AM ET. Participating from the Palisade Bio management team will be Tom Hallam, Ph.D., Chief ...
By Palisade Bio
-
Palisade Bio (Nasdaq: PALI) To Participate In The 2022 Virtual Growth Conference Presented By Maxim Group And Hosted By M-Vest
Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today announced that of Palisade Bio, will participate in the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, taking place on March 28–30, 2022. As part of the conference, a video webcast of the ...
By Palisade Bio
-
Palisade Bio (Nasdaq: PALI) Announces Analysis Demonstrating LB1148 Reduced The Extent And Severity Of Post-Surgical Intraabdominal Adhesions By 93%
Data from Pooled-Analysis of Enteral Protease Inhibitor LB1148 Demonstrated 72% Reduction in the Risk of Adhesion Formation in Patients Undergoing Bowel Resection Surgery Company to Host Conference Call on Wednesday, March 16, 2022, at 8:30 a.m. EST Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) ...
By Palisade Bio
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you